DFFVX
Price
$40.19
Change
+$4.46 (+12.48%)
Updated
Feb 3 closing price
Net Assets
14.92B
JDSAX
Price
$25.64
Change
+$1.99 (+8.41%)
Updated
Feb 3 closing price
Net Assets
1.18B
Interact to see
Advertisement

DFFVX vs JDSAX

Header iconDFFVX vs JDSAX Comparison
Open Charts DFFVX vs JDSAXBanner chart's image
DFA US Targeted Value I
Price$40.19
Change+$4.46 (+12.48%)
VolumeN/A
Net Assets14.92B
Janus Henderson Small Cap Value A
Price$25.64
Change+$1.99 (+8.41%)
VolumeN/A
Net Assets1.18B
DFFVX vs JDSAX Comparison Chart in %
View a ticker or compare two or three
VS
DFFVX vs. JDSAX commentary
Feb 05, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DFFVX is a Buy and JDSAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
DFFVX has more cash in the bank: 14.9B vs. JDSAX (1.18B). DFFVX pays higher dividends than JDSAX: DFFVX (1.58) vs JDSAX (0.14). DFFVX was incepted earlier than JDSAX: DFFVX (26 years) vs JDSAX (17 years). JDSAX (1.46) is less costly to investors than DFFVX (0.30). JDSAX is a more actively managed with annual turnover of: 37.00 vs. DFFVX (10.00). DFFVX has a lower initial minimum investment than JDSAX: DFFVX (0) vs JDSAX (2500). DFFVX annual gain was more profitable for investors over the last year : 17.44 vs. JDSAX (10.87). DFFVX return over 5 years is better than : 62.65 vs. JDSAX (16.62).
DFFVXJDSAXDFFVX / JDSAX
Total Expense Ratio0.291.4620%
Annual Report Gross Expense Ratio0.301.4621%
Fund Existence26 years17 years-
Gain YTD8.6808.186106%
Front LoadN/A6%-
Min. Initial Investment02500-
Min. Initial Investment IRAN/AN/A-
Net Assets14.9B1.18B1,262%
Annual Yield % from dividends1.580.141,142%
Returns for 1 year17.4410.87160%
Returns for 3 years37.636.88547%
Returns for 5 years62.6516.62377%
Returns for 10 years141.5856.49251%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
O61.460.93
+1.54%
Realty Income Corp
OGS80.510.59
+0.74%
ONE GAS
VYNE0.57N/A
+0.49%
VYNE Therapeutics
MAMK13.00N/A
N/A
Maxsmaking Inc
CTMX6.07-0.02
-0.33%
CytomX Therapeutics